ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,536Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 2456

$1.41M Total Retail Price of All Prescriptions

Rank: 14 out of 2456

751 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 751 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 751 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 19,926 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,241 905 1 9
SIMVASTATIN 1,116 860 2 2
FUROSEMIDE 858 708 3 8
METOPROLOL TARTRATE 841 688 4 10
AMLODIPINE BESYLATE 816 734 5 5
OMEPRAZOLE 737 472 6 3
LISINOPRIL 681 515 7 1
TRAZODONE HCL 578 435 8 17
GABAPENTIN 551 351 9 16
LEVOTHYROXINE SODIUM 502 378 10 4
CITALOPRAM HBR 500 404 11 14
METFORMIN HCL 473 366 12 11
DIVALPROEX SODIUM 443 344 13 51
METOPROLOL SUCCINATE 333 275 14 13
POTASSIUM CHLORIDE 325 266 15 33
DONEPEZIL HCL 315 297 16 23
NAMENDA 315 309 16 42
CLOPIDOGREL 310 249 18 55
MIRTAZAPINE 304 252 19 29
ATENOLOL 299 223 20 6
PANTOPRAZOLE SODIUM 290 239 21 37
PREDNISONE 277 213 22 39
QUETIAPINE FUMARATE 271 192 23 47
ATORVASTATIN CALCIUM 252 201 24 12
TAMSULOSIN HCL 243 206 25 32
ISOSORBIDE MONONITRATE ER 240 224 26 48
RISPERIDONE 229 157 27 50
BISOPROLOL-HYDROCHLOROTHIAZIDE 223 164 28 223
HYDROCODONE-ACETAMINOPHEN 223 140 S3 28 20
TRAMADOL HCL 215 157 30 24
OLANZAPINE 214 140 31 57
ADVAIR DISKUS 198 173 32 36
LANTUS 198 126 32 44
CLOZAPINE 195 26 34 75
FLUOXETINE HCL 192 95 35 45
HYDROCHLOROTHIAZIDE 191 116 36 7
SERTRALINE HCL 186 163 37 21
RANITIDINE HCL 177 148 38 31
PLAVIX 174 147 39 79
POLYETHYLENE GLYCOL 3350 174 117 39 64
GLIPIZIDE 169 142 41 46
PROAIR HFA 168 112 42 22
IBUPROFEN 168 61 42 52
LAMOTRIGINE 167 68 44 120
NOVOLOG 164 111 45 100
GLYBURIDE 162 110 R 46 40
LEVEMIR 150 125 47 174
PROPRANOLOL HCL 147 59 48 108
FAMOTIDINE 144 104 49 84
SPIRIVA 144 111 49 43
LIDODERM 136 105 51 58
OXYCODONE-ACETAMINOPHEN 135 87 S2 52 35
DIGOXIN 134 118 53 49
CARBIDOPA-LEVODOPA 131 105 54 82
ALENDRONATE SODIUM 127 115 55 19
AZITHROMYCIN 123 77 56 60
NIFEDIPINE ER 122 104 57 61
JANUVIA 119 98 58 81
CARVEDILOL 117 77 59 54
CYMBALTA 115 56 60 65
LOSARTAN POTASSIUM 109 86 61 18
FINASTERIDE 104 86 62 66
GEMFIBROZIL 103 59 63 93
LOVASTATIN 97 76 64 34
LEVETIRACETAM 96 32 65 90
LABETALOL HCL 95 72 66 128
LACTULOSE 93 36 67 88
CIPROFLOXACIN HCL 92 50 68 87
AMITRIPTYLINE HCL 92 55 R 68 83
METOCLOPRAMIDE HCL 91 64 70 170
PAROXETINE HCL 91 57 70 56
CRESTOR 90 74 72 25
PRAVASTATIN SODIUM 88 66 73 15
ZOLPIDEM TARTRATE 86 56 74 28
DETROL LA 85 64 75 228
NOVOLIN R 85 72 75 173
SEROQUEL 85 54 75 102
ZETIA 85 62 75 86
VENLAFAXINE HCL ER 83 66 79 92
CEPHALEXIN 83 49 79 153
OXYCODONE HCL 83 52 S2 79 38
KLOR-CON 10 78 70 82 133
GLYBURIDE-METFORMIN HCL 78 67 R 82 238
VERAPAMIL ER 78 72 82 91
GLIMEPIRIDE 74 47 85 74
HYDRALAZINE HCL 73 53 86 105
DILTIAZEM HCL 72 68 87 207
PRADAXA 71 49 88 225
HALOPERIDOL 71 29 88 137
MECLIZINE HCL 71 64 88 107
NYSTOP 70 41 91 125
NAPROXEN 70 36 91 109
INSULIN SYRINGE 68 49 93 72
ALLOPURINOL 68 66 93 27
IPRATROPIUM-ALBUTEROL 66 56 95 85
KLOR-CON M20 64 50 96 69
NYSTATIN 63 45 97 99
CLOTRIMAZOLE-BETAMETHASONE 62 39 98 182
COLCRYS 61 39 99 171
VALPROIC ACID 61 36 99 261
CHLORPROMAZINE HCL 61 12 99 274
BUPROPION HCL SR 61 17 99 119
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 41 103 41
NEXIUM 60 54 103 80
HUMALOG 59 36 105 123
MUPIROCIN 55 32 106 209
HYDROXYZINE HCL 55 22 R 106 177
SINGULAIR 54 23 108 149
CELEBREX 53 46 109 127
FLOVENT HFA 53 29 109 104
CYCLOBENZAPRINE HCL 52 26 R 111 77
TRIAMTERENE-HCTZ 51 36 112 53
PHENYTOIN SODIUM EXTENDED 51 0 112 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.